Trophic factors in cerebrospinal fluid and spinal cord of patients with tropical spastic paraparesis, HIV, and Creutzfeldt-Jakob disease.
HTLV-1-associated myelopathy/tropical spastic paraparesis (TSP/HAM) is a chronic CNS disease characterized by axomyelinic degeneration of the long axons of corticospinal tracts. Levels of NGF, NT-3, NT-4/5, BDNF, GDNF, CNTF, and FGF-2 were measured in the cerebrospinal fluid (CSF) of 21 TSP/HAM patients and 20 controls. NGF, BDNF, and FGF-2 levels were also determined in 19 patients with HIV motor cognitive motor syndrome, and in 21 subjects diagnosed with Creutzfeldt Jakob disease (CJD). No significant differences were detected in the concentrations of NGF, BDNF, NT-3, NT-4/5, GDNF, and CNTF in the CSF between TSP/HAM patients and controls. FGF-2 was significantly lower in the CSF of the three groups of patients compared with controls; the HIV group exhibited the lowest values. HIV patients differed from TSP/HAM in their significantly higher levels of NGF and lower levels of BDNF and FGF-2, whereas CJD patients differed only in their higher levels of NGF. Immunohistochemical studies were done of trophic factors (NGF and FGF-2) and neurotrophin receptors (trkA and p75) in spinal cord and motor cortical areas from anatomopathological cases of TSP/HAM. Results indicated that NGF is expressed in motoneurons and oligodendrocytes of the posterior column of the spinal cord. FGF-2 was detected in motoneurons and spinal cord vessels. p75 receptor was detected in cortical neurons. The absence of a significant change in the trophic factor levels in TSP/HAM may be attributed to a selective axonal lesion in a slow process.
Albrecht
David
D
Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago, Chile.
García
Lorena
L
Cartier
Luis
L
Kettlun
Ana M
AM
Vergara
Carmen
C
Collados
Lucia
L
Valenzuela
M Antonieta
MA
D000328:Adult; D000368:Aged; D015153:Blotting, Western; D019208:Brain-Derived Neurotrophic Factor / Q000134:cerebrospinal fluid*; D007562:Creutzfeldt-Jakob Syndrome / Q000134:cerebrospinal fluid* / Q000150:complications / Q000821:virology; D016222:Fibroblast Growth Factor 2 / Q000134:cerebrospinal fluid*; D015658:HIV Infections / Q000134:cerebrospinal fluid* / Q000150:complications; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D020932:Nerve Growth Factor / Q000134:cerebrospinal fluid*; D015493:Paraparesis, Tropical Spastic / Q000134:cerebrospinal fluid* / Q000150:complications / Q000821:virology; D020800:Receptor, Nerve Growth Factor / Q000276:immunology; D020917:Receptor, trkA / Q000276:immunology; D013116:Spinal Cord / Q000378:metabolism* / Q000473:pathology
D019208:Brain-Derived Neurotrophic Factor; D020800:Receptor, Nerve Growth Factor; D016222:Fibroblast Growth Factor 2; D020932:Nerve Growth Factor; D020917:Receptor, trkA